论文部分内容阅读
目的研究回生口服液联合放化疗治疗晚期肺癌的疗效。方法晚期肺癌患者80例,经肺CT、磁共振共显像技术(MRI)明确诊断肺癌,痰脱落细胞检查找到癌细胞;经支气管纤维镜检查提取病理明确诊断为晚期肺癌。随机分为两组,每组40例。A组:单进行放化疗治疗;B组:采用回生口服液联合放化疗治疗。观察两种治疗方法的疗效,观察期为1.5个月。结果 A组和B组之间的治愈率差异具有统计学意义(χ2=3.22,P<0.05)。结论采用回生口服液联合放化疗治疗的效果优于单用放化疗治疗晚期肺癌。在临床工作中,可以通过采用回生口服液联合放化疗来治疗晚期肺癌,能够取得较好的效果。
Objective To study the curative effect of regenerative oral liquid combined with chemoradiotherapy in the treatment of advanced lung cancer. Methods Eighty patients with advanced lung cancer were diagnosed lung cancer and sputum exfoliated cells by CT and magnetic resonance imaging (MRI). The cancerous cells were detected by bronchial fibroscopy. The pathological diagnosis of advanced lung cancer was confirmed by bronchofibroscopy. Randomly divided into two groups, 40 cases in each group. Group A: single radiotherapy and chemotherapy; Group B: the use of regenerative oral chemotherapy and radiotherapy and chemotherapy. Observed the efficacy of the two treatment methods, the observation period of 1.5 months. Results The cure rate between group A and group B was statistically significant (χ2 = 3.22, P <0.05). Conclusion The effect of combined oral chemotherapy and radiotherapy and chemotherapy is better than that of radiotherapy and chemotherapy for advanced lung cancer. In clinical work, we can achieve better results by using the regenerative oral solution combined with chemoradiotherapy to treat advanced lung cancer.